Related Experiment Video
Updated: Jan 20, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
p21 in Cancer Research
1Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA. bahar.shamloo@hci.utah.edu.
Abstract:
p21 functions as a cell cycle inhibitor and anti-proliferative effector in normal cells, and is dysregulated in some cancers. Earlier observations on p21 knockout models emphasized the role of this protein in cell cycle arrest under the p53 transcription factor activity. Although tumor-suppressor function of p21 is the most studied aspect of this protein in cancer, the role of p21 in phenotypic plasticity and its oncogenic/anti-apoptotic function, depending on p21 subcellular localization and p53 status, have been under scrutiny recently. Basic science and translational studies use precision gene editing to manipulate p21 itself, and proteins that interact with it; these studies have led to regulatory/functional/drug sensitivity discoveries as well as therapeutic approaches in cancer field. In this review, we will focus on targeting p21 in cancer research and its potential in providing novel therapies.
Insights
The protein p21, a cell cycle inhibitor, has dual roles in cancer. Targeting p21 offers potential for novel cancer therapies by modulating its function and subcellular localization.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- p21 is a key cell cycle inhibitor and anti-proliferative factor in normal cells.
- Its function is often dysregulated in various cancers.
- While known for tumor suppression, p21's role in cancer is complex, involving phenotypic plasticity and apoptosis regulation.
Purpose of the Study:
- To review the multifaceted roles of p21 in cancer.
- To explore how p21's subcellular localization and p53 status influence its oncogenic or anti-apoptotic functions.
- To highlight the therapeutic potential of targeting p21 in cancer treatment.
Main Methods:
- Review of basic science and translational studies.
- Analysis of research utilizing precision gene editing to manipulate p21 and interacting proteins.
- Examination of findings related to p21 regulation, function, and drug sensitivity.
Main Results:
- p21 exhibits context-dependent functions in cancer, acting as both a tumor suppressor and an oncogene.
- Subcellular localization and p53 status are critical determinants of p21's activity.
- Targeting p21 has yielded insights into cancer regulation and drug sensitivity.
Conclusions:
- Understanding the complex roles of p21 is crucial for developing effective cancer therapies.
- Targeting p21, considering its localization and p53 status, presents a promising avenue for novel therapeutic strategies.
- Further research into p21 manipulation could lead to significant advancements in cancer treatment.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

